PGV-1 is a potent antimitotic agent
Carcinogenesis can be involved in the malfunctioning of programmed cell death Most of the anticancer drug in current use induce apoptosis in susceptible cells. The fact that disparate agent interacting with different targets seem to induce cell death through some common mechanism suggest that antica...
Saved in:
Main Authors: | Barinta Widaryanti (Author), Edy Meiyanto (Author), Muhammad Da'i (Author), Masashi Kawaichi (Author) |
---|---|
Format: | Book |
Published: |
Universitas Gadjah Mada,
2008-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anti-proliferative and Anti-metastatic Potential of Curcumin Analogue, Pentagamavunon-1 (PGV-1), Toward Highly Metastatic Breast Cancer Cells in Correlation with ROS Generation
by: Edy Meiyanto, et al.
Published: (2019) -
Effects of pentagamavunon-0 (PGV-0) as alternative analgesics on orthodontic tooth movement in rats
by: Cendrawasih Andusyana Farmasyanti, et al.
Published: (2019) -
Bioinformatics Analysis Confirms the Target Protein Underlying Mitotic Catastrophe of 4T1 Cells under Combinatorial Treatment of PGV-1 and Galangin
by: Nurul Awali Fauziyah Hasbiyani, et al.
Published: (2021) -
Potent and Selective Benzothiazole-Based Antimitotics with Improved Water Solubility: Design, Synthesis, and Evaluation as Novel Anticancer Agents
by: Laura Gallego-Yerga, et al.
Published: (2023) -
Preparation and Cytotoxic Evaluation of PGV-1 Derivative, CCA-1.1, as a New Curcumin Analog with Improved-Physicochemical and Pharmacological Properties
by: Rohmad Yudi Utomo, et al.
Published: (2022)